# Aktis Oncology, Inc.: Form SCHEDULE 13D, filed Jan 14, 2026

- Company: [Aktis Oncology, Inc.](/companies/akts.md) (CIK 2035832)
- Form: SCHEDULE 13D
- Filed: 2026-01-14
- Accepted by EDGAR: Jan 14, 2026, 16:58 ET
- Period: not reported
- Accession: 0001193125-26-013015
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2035832/000119312526013015/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2035832/000119312526013015/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2035832/000119312526013015/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jan 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-013015. Last ingested by Listed: Nov 12, 2026, 18:12 ET. No prices; not investment advice.